US2007014872A1PendingUtilityA1
Compositions for regenerating defective or absent myocardium
Assignee: CORMATRIX CARDIOVASCULAR INCPriority: Jul 15, 2005Filed: Jun 6, 2006Published: Jan 18, 2007
Est. expiryJul 15, 2025(expired)· nominal 20-yr term from priority
A61L 2430/20A61L 2300/45A61L 27/3683A61L 27/3687A61K 38/1825A61K 38/1741A61K 9/0019A61L 27/40A61L 27/58A61K 35/407A61L 2300/412A61L 27/3629A61K 35/22A61K 38/1841A61K 35/37A61L 27/3873A61K 31/7088A61L 2300/426A61L 27/367A61K 35/50A61K 35/38A61L 27/3834A61K 48/00A61K 31/726A61L 2300/414A61L 27/227A61L 27/54A61K 35/34A61L 2300/64A61K 35/545A61L 27/3633A61L 2430/30A61L 2400/06A61K 38/39A61K 35/28A61K 31/711A61K 31/7105A61L 27/3804
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition can also have an extracellular matrix scaffold component of any formulation, then including also added cells, proteins, or other components to optimize the regenerative process and restore cardiac function. Methods for regenerating defective or absent myocardium apply a composition to a site of myocardium in need of regeneration using a delivery mode appropriate for the particular formulation.
Claims
exact text as granted — not AI-modified1 . A method of inducing angiogenesis in myocardium at a site of ischemia, comprising contacting said ischemic myocardium with a composition an emulsified or injectable extracellular matrix composition from a mammalian or synthetic source in an amount effective to induce angiogenesis in the myocardium at the site of ischemia.
2 . A method of inducing angiogenesis in myocardium at a site of ischemia, comprising contacting said ischemic myocardium with a composition for regenerating defective or absent myocardium and restoring cardiac function in an amount effective to induce angiogenesis in the myocardium at the site of ischemia, said composition comprising an emulsified or injectable extracellular matrix composition derived from a mammalian or synthetic source, said composition further comprising an additional component selected from the group consisting of:
a) a cell, b) a peptide, polypeptide, or protein, c) a vector having a DNA capable of targeted expression of a selected gene, and d) a nutrient, a sugar, a fat, a lipid, an amino acid, a nucleic acid, a ribo-nucleic acid, an organic molecule, an inorganic molecule, a small molecule, a drug, or a bioactive molecule.
3 . A method of inducing angiogenesis in myocardium at a site of ischemia, comprising contacting said ischemic myocardium with a composition for regenerating defective or absent myocardium and restoring cardiac function in an amount effective to induce angiogenesis in the myocardium at the site of ischemia, said composition for regenerating defective or absent myocardium and restoring cardiac function comprising at least a portion of an extracellular matrix scaffold derived from a mammalian source and also comprising an additional component selected from the groups consisting of:
a) a plurality of synthetic extracellular matrix-like scaffold-forming molecules b) a cell, c) a peptide, polypeptide, or protein, and d) a vector having a DNA capable of targeted expression of a selected gene, and e) a nutrient, a sugar, a fat, a lipid, an amino acid, a nucleic acid, a ribo-nucleic acid, an organic molecule, an inorganic molecule, a small molecule, a drug, or a bioactive molecule.
4 . The method of claim 1 , 2 , or 3 wherein said contacting step comprises delivering the composition by a delivery means selected from the group consisting of injecting, suturing, stapling, injecting with a percutaneous catheter, CO 2 powering emission of fine emulsion, micronizing an injectable solution, ink jet delivery, physically depositing a sponge, physically depositing a patch, physically depositing a strip, and physically depositing a formed scaffold of any shape.Join the waitlist — get patent alerts
Track US2007014872A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.